AU Stock MarketDetailed Quotes
OSLO OncoSil Medical Ltd
- 0.001
- -0.001-50.00%
20min DelayMarket Closed Nov 6 15:15 AET
4.48MMarket Cap0.00P/E (Static)
0.001High0.001Low41.54KVolume0.001Open0.002Pre Close42.00Turnover0.00352wk High0.00%Turnover Ratio4.48BShares0.00152wk Low--EPS TTM3.94MFloat Cap0.006Historical High0.00P/E (Static)3.94BShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About OncoSil Medical Ltd Company
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.
Company Profile
SymbolOSLO
Company NameOncoSil Medical Ltd
Founded2005
MarketASX
Employees22
Fiscal Year Ends06-30
Address7 Eden Park Drive Level 5
CitySydney
CountryAustralia
Zip Code2113
Phone+61 289359629
Websitehttps://www.oncosil.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Nigel Lange
- Executive Director, Chief Executive Officer and Managing Director
- --
- Christian Dal Cin
- Chief Financial Officer
- --
- Dr. Jon Bell
- Chief Medical Officer
- --
- Douglas Cubbin
- Non-Executive Chairman of the Board
- --
- Dr Gabriel Liberatore
- Non-Executive Director
- --
- Renzo DiCarlo
- Head of Transformation
- --
- Henk Tissing
- Global Head of Clinical Affairs
- --
- David Turner
- Global Head of Medical Affairs
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data